The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat ...
The FDA recently expanded the approval of the breast cancer drug Kisqali to treat patients with earlier stages of the disease. Thousands of women diagnosed with early-stage breast cancer will have ...
"Today's authorization expands the options for individuals with respiratory symptoms to receive information about their health from the comfort of their home." "The FDA continues to take actions ...
Following the first approval of generic versions of type 2 diabetes drug, Actos, the FDA has also approved updated prescribing information for Tradjenta tablets, for add-on therapy to insulin ...
Opens in a new tab or window The FDA expanded the approval of the bivalent ... Pfizer announced on Tuesday. The approval expands on the vaccine's existing indications for the prevention of RSV ...
with the pediatric approval expected to add another $50 to $100 million. While Jazz's sleep disorder drugs are approved for the same condition as Lumryz, Xywav has the FDA's expanded nod to treat ...
The Food and Drug Administration (FDA) expanded the approval of Jylamvo (methotrexate) to include children with acute lymphoblastic leukemia, marking it as the only oral liquid formulation of ...
After receiving a green light earlier this year from the FDA, Medtronic has now collected a European approval for the latest version of its transcatheter aortic valve replacement implant.
Larry Biegelsen has given his Buy rating due to a combination of factors, including the recent FDA approval of NovoCure’s Optune for treating non-small cell lung cancer (NSCLC) with a broad label.
The U.S. Food and Drug Administration (FDA) has approved the fourth indication ... the company announced late Friday. With the latest approval, the injectable will be allowed for use in adults ...